Acne Back Chest Treatment

Description

GLYTONE Acne Back & Chest Treatment Spray is a topical acne therapy formulated with 2% salicylic acid as the active ingredient. This preparation also contains gluconolactone, a polyhydroxy acid (PHA), and aloe, which may provide additional skin benefits. The product is presented in a spray dosage form, with a total volume of 240 mL (8.0 FL. OZ.).

Uses and Indications

This drug is indicated for the treatment of acne. It effectively dries and clears acne blemishes, facilitating the healing of the skin. The formulation penetrates pores to eliminate most acne blemishes, including blackheads and whiteheads, and helps prevent the development of new acne lesions.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product should be sprayed directly onto cleansed affected areas of the back, shoulders, and chest. The spray should be held 3 to 6 inches away from the skin during application. It is recommended to apply the spray one to three times daily, depending on the severity of the condition and as directed by a healthcare professional.

For optimal application, the pump is designed to work upside down. It is important to allow the sprayed area to dry completely before putting on clothing to prevent any potential irritation.

To minimize the risk of excessive skin drying, it is advisable to start with one application daily. Based on individual response, the frequency may be gradually increased to two to three times daily. If the patient experiences bothersome dryness or peeling, the application frequency should be reduced to once a day or every other day.

Contraindications

There are no contraindications listed for this product. However, it is advised that the product should not be inhaled. Inhalation may pose risks that are not specified in the available data.

Warnings and Precautions

For external use only. It is imperative that this product is not ingested, as ingestion may lead to serious health consequences. In the event of accidental swallowing, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

This product is flammable; therefore, it must be kept away from fire or flame to prevent the risk of combustion. Proper storage and handling practices should be observed to ensure safety during use.

Side Effects

Patients using this product should be aware that it is intended for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

Additionally, care should be taken to avoid contact with the eyes. Should eye contact occur, it is advised to rinse thoroughly with water to alleviate any potential discomfort. Patients are also cautioned to spray the product in a well-ventilated area and to avoid inhalation, as this may lead to respiratory irritation.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Back Chest Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal impacts associated with its use in pregnant patients. Healthcare professionals should exercise caution when prescribing this medication to women of childbearing potential and consider the lack of information regarding its effects on pregnancy and fetal outcomes. It is advisable to weigh the potential benefits against any unknown risks when making treatment decisions for pregnant patients.

Lactation

There are no specific warnings or precautions regarding the use of this product in lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. Healthcare professionals are advised to instruct patients or caregivers to seek medical help or contact a Poison Control Center without delay if the substance has been ingested.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment and appropriate management strategies should be implemented based on clinical presentation and available guidelines.

It is imperative that healthcare providers remain vigilant and prepared to initiate supportive care and symptomatic treatment as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Providers should emphasize the importance of avoiding contact with the eyes. Instruct patients that if eye contact occurs, they should rinse their eyes thoroughly with water to alleviate any potential discomfort.

Additionally, patients should be counseled to spray the medication in a well-ventilated area and to avoid inhaling the spray to ensure safe usage.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which are essential for identification and inventory management. It is crucial to store the product in a safe environment, ensuring it is kept away from fire or flame to prevent any potential hazards.

For optimal storage conditions, it is recommended to maintain the product at a controlled temperature range, although specific temperature details are not provided. Additionally, appropriate container requirements should be adhered to, ensuring that the product is stored in a manner that protects its integrity. Special handling needs must also be observed to ensure safety and efficacy during use.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Acne Back Chest Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)